Exploring the Global Nilotinib Market: Current Landscape and Future Prospects
Market Overview The Nilotinib Market is driven by the increasing prevalence of CML worldwide, coupled with the rising demand for targeted therapies. CML is a type of blood cancer that affects the bone marrow and blood cells, and nilotinib has proven to be an effective treatment option, offering better responses and longer remission periods compared to traditional chemotherapy. Nilotinib is a highly potent and selective tyrosine kinase inhibitor primarily used in the treatment of chronic myeloid leukemia (CML). It specifically targets the BCR-ABL kinase, an abnormal enzyme responsible for the uncontrolled growth and proliferation of cancerous cells in CML patients.…
- Date: March 7, 2024
- Author: Timmy Thomas
- Category: PharmiWeb